E2F1 and gastric cancer: Other studies have also demonstrated that that ANRIL expression, which was induced through ATM-E2F1 signaling pathway, increased notably in gastric cancer tissues and non-small cell lung cancer tissues, with reports highlighting its ability to promote proliferation while inhibiting the apoptosis of cancer cells [10,14].